Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Conditions

• Physical Exercise
• Physiological Reactivity to Cues

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• 36-session targeted physical exercise program delivered twice weekly — OTHER
  Participant will be enrolled for approximately 18-20 weeks (about 4-5 months). This includes a baseline assessment, participation in a 36-session targeted physical exercise program

Study Details

Patients with pancreatic cancer receiving neoadjuvant chemotherapy often experience functional decline, treatment interruptions, and clinical deterioration, and these risks may be amplified when frailty is present.

Key Dates

Start date

Jun 15, 2026

Status verified

Jun 2026

Primary completion

Apr 30, 2031

Completion

Apr 30, 2032

Study Design

Enrollment

25 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Arms

• Other: physical exercise to frail adults w pancreatic ca who are receiving neoadjuvant chemotherapy
  Eligible participants may be enrolled if they plan to initiate or are actively receiving neoadjuvant chemotherapy, provided they meet all inclusion criteria and have no contraindications to supervised exercise

Primary Outcome Measure

Recruitment rate [ Time Frame: 6 months ]

Central Contacts

• Aslam Ejaz, MD
  312 996 6666
  [email protected]
• Zoey Zhou
  312-996-6666
  [email protected]

Locations (1)

Find similar trials in Chicago, IL